Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

orBec

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

64 API Suppliers, 18 USDMF, 12 CEP/COS, 2 JDMF, 7 EU WC, 2 KDMF, 15 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

FINISHED DOSAGE FORMULATIONS

307 FDF Dossiers, 14 FDA Orange Book, 220 Europe, 7 Canada, 16 Australia, 15 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 DKSH, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures, 2 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Thickeners and Stabilizers, 17 Fillers, Diluents & Binders, 15 Solubilizers, 9 Parenteral, 9 Direct Compression, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Controlled & Modified Release, 5 Disintegrants & Superdisintegrants, 5 Granulation, 4 Chewable & Orodispersible Aids, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 3 Surfactant & Foaming Agents, 3 Topical, 3 Emulsifying Agents, 3 Taste Masking, 1 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 18 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 70 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

44 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Sicor Societa Italiana Corticosteroidi Srl	Italy	Sicor Societa (') Italiana Corticosteroidi S. r. l.	218MF10626	Beclomethasone propionate "Teva/Law"	2006-07-20	2006-07-20	Piazzale Luigi Cadorna, 4 - 20123 MILANO, Italy
29/11/2025	Sicor Societa Italiana Corticosteroidi Srl	Italy	Sicor Societa (') Italiana Corticosteroidi S. r. l.	218MF10532	Beclomethasone dipropionate (Teva)	2006-06-01	2006-06-01	Piazzale Luigi Cadorna, 4-20123 MILANO, Italy

OrBec

orBec

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

64 API Suppliers

18 USDMF

12 CEP/COS

2 JDMF

7 EU WC

2 KDMF

15 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

FINISHED DOSAGE FORMULATIONS

307 FDF Dossiers

14 FDA Orange Book

220 Europe

7 Canada

16 Australia

15 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

2 DKSH

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Kirsch Pharma

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures

2 Kerry

2 Keval Exports

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 Silverline Chemicals

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Thickeners and Stabilizers

17 Fillers, Diluents & Binders

15 Solubilizers

9 Parenteral

9 Direct Compression

8 Co-Processed Excipients

6 Rheology Modifiers

5 Controlled & Modified Release

5 Disintegrants & Superdisintegrants

5 Granulation

4 Chewable & Orodispersible Aids

4 Coating Systems & Additives

4 Film Formers & Plasticizers

3 Surfactant & Foaming Agents

3 Topical

3 Emulsifying Agents

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons